Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts ultimate limit of human lifespan TV Pyrkov et al, BioRX IV, April 26, 2019

Main|Search|PHGKB




Last Posted: Apr 29, 2019

---

• Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts ultimate limit of human lifespan
  TV Pyrkov et al, BioRX IV, April 26, 2019
• Effect of genetic polymorphisms on Alzheimer's disease treatment outcomes: an update.
  Sumirtanurdin Riyadi et al. Clinical interventions in aging 2019 14631-642
• Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis.
  Fiorito Giovanni et al. Aging 2019 Apr 11(7) 2045-2070
• Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine.
  Eid Aseel et al. Pharmacology & therapeutics 2019 Mar
• Current genetic counseling practice in the United States following positive non-invasive prenatal testing for sex chromosome abnormalities.
  Fleddermann Lauren et al. Journal of genetic counseling 2019 Apr
• Translating insights into tumor evolution to clinical practice: promises and challenges.
  Fittall Matthew W et al. Genome medicine 2019 Mar 11(1) 20
• Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology.
  Brane Andrew C et al. Cells 2019 Feb 8(2)
• Moving pharmacoepigenetics tools for depression toward clinical use.
  Hack Laura M et al. Journal of affective disorders 2019 Feb 249336-346
• Towards a more precise and individualized assessment of breast cancer risk.
  Wood Marie E et al. Aging 2019 Feb
• Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?
  Squassina Alessio et al. Cells 2019 Jan 8(1)

more